This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

FEI Company At JP Morgan Healthcare Conference Call Transcript

Stocks in this article: FEIC

FEI Company ( FEIC)

JP Morgan Healthcare Conference Call Transcript

January 13, 2012 3:00 PM ET

Executives

Donald Kania – CEO

Presentation

Unidentified Analyst

All right, good afternoon. We are about to get started here. We are very happy to have FEI Company and the Company’s CEO, Don Kania to present. The breakout for this session will be in the Georgian Room.

Donald Kania

Okay. Thanks a lot. It’s good to have everybody visit, appreciate your time and give you a view of the story of FEI. So, the usual Safe Harbor statements, don’t believe anything I say and don’t hold it against us. And then, just so, for those of you who knew the story, it was FEI. We make really fancy microscopes that see atoms basically. We can see and manipulate the atomic scale and we apply that to a lot of different markets.

So, our thesis is, new technology leader in the marketplace and then, customize those. We have three technologies that are core to this and customize those technologies for those markets. So, our R&D investment is highly leveraged overall. And you can see some – we’re all about imagery and analytics that is seeing things that are very small and then, telling you which atoms are which. So, there is a variety of industries that I will talk about that we serve.

I think overall there are two parts of the puzzle. One is the many industries and the other is that there is many geographic – there is a geographic diversity of the company and I love all these pictures. In the upper right, there is President Obama in front of an FEI microscope. That happens when Intel Corporation had Obama visit and when Intel wanted to show off what they were doing, what did they do? They put him in front of an FEI microscope and we are quite proud of that. So that’s our semiconductor business we call it electronics overall. Below that Dr. Daniel Shechtman in our research business won the Nobel Prize in chemistry this year and we are especially proud, there he is in front of the microscope.

1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,678.70 +6.10 0.03%
S&P 500 2,057.09 +5.27 0.26%
NASDAQ 4,771.7630 +13.8840 0.29%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs